Nestlé’s 12Bln Deal to Help Regain Chinese Baby Food Market04-23 15:14 Caijing
Nestle SA has agreed to buy Pfizer’s infant-nutrition business with $11.9 billion, a move could help Nestle regain the Chinese baby food market, Bloomberg reported Monday.
Pfizer on Sunday chose Nestle over Danone SA , which also bid about $11 billion, Bloomberg quoted an anonymous source as saying.
The purchase will help Nestle, already the top seller of infant-nutrition products, regain traction in the Chinese baby- food market where Pfizer has a 7 percent share, according to the report.
Nestle has been losing market share in the country since 2005, when it withdrew two varieties of Neslac milk powder after authorities found they contained excessive iodine.
China's infant nutrition market is a highly competitive one led by Dumex and Mead-Johnson.
Statistics show Nestle had become the 3rd largest infant nutrition
manufacturer in the Chinese market with a 10.58% share, following 16.76%-share
Dumex and 12.06%-share Mead-Johnson by the end of July in 2010.
Editors’ Picks »
- 1Highlights: Premier Li's Government Work Report
- 2Xi Urges Shanghai to Spearhead Reforms, Opening-up
- 3China’s New Funds Oustanding for Forex Surge in Jan.
- 4NDRC Plans Internal Reforms
- 5Debris Spotted Possibly from Missing MH370: Vietnam Navy Officials
- 6Shanghai Index Plunges on Slowdown Concerns
- 7China's 'Father of Hybrid Rice' Nominated for 2014 Nobel Peace Prize
- 8Chinese Tycoon Upbeat About Property Market in 10 Years
- 9Latham & Watkins: How Exposed Are Holders of Offshore Chinese Bonds?
- 10China’s Huayi Plans $150 million Injectons in Studio 8